nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—CYP2D6—Parkinson's disease	0.522	0.583	CbGaD
Acebutolol—ABCB1—Parkinson's disease	0.373	0.417	CbGaD
Acebutolol—Alprenolol—HTR1A—Parkinson's disease	0.00101	0.134	CrCbGaD
Acebutolol—Pindolol—HTR1A—Parkinson's disease	0.00087	0.115	CrCbGaD
Acebutolol—Betaxolol—CYP2D6—Parkinson's disease	0.000731	0.0967	CrCbGaD
Acebutolol—Bisoprolol—CYP2D6—Parkinson's disease	0.000706	0.0934	CrCbGaD
Acebutolol—Oxprenolol—CYP2D6—Parkinson's disease	0.000663	0.0878	CrCbGaD
Acebutolol—Alprenolol—CYP2D6—Parkinson's disease	0.000607	0.0803	CrCbGaD
Acebutolol—Metoprolol—CYP2D6—Parkinson's disease	0.000564	0.0747	CrCbGaD
Acebutolol—Pindolol—CYP2D6—Parkinson's disease	0.000522	0.0691	CrCbGaD
Acebutolol—Atenolol—ABCB1—Parkinson's disease	0.000517	0.0684	CrCbGaD
Acebutolol—Propranolol—HTR1A—Parkinson's disease	0.000475	0.0628	CrCbGaD
Acebutolol—Metoprolol—ABCB1—Parkinson's disease	0.000403	0.0533	CrCbGaD
Acebutolol—Propranolol—CYP2D6—Parkinson's disease	0.000285	0.0377	CrCbGaD
Acebutolol—Propranolol—ABCB1—Parkinson's disease	0.000203	0.0269	CrCbGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.000115	0.00118	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000114	0.00117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000114	0.00117	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000114	0.00117	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000113	0.00116	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000113	0.00116	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ND3—Parkinson's disease	0.000112	0.00115	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MCCC1—Parkinson's disease	0.000112	0.00115	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000112	0.00115	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000112	0.00114	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000111	0.00114	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.000111	0.00113	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000109	0.00112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.000109	0.00111	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000106	0.00109	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000106	0.00109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000106	0.00109	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TALDO1—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—OMD—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000104	0.00107	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000104	0.00107	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000104	0.00107	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000104	0.00106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000101	0.00104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.000101	0.00103	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NDUFB11—Parkinson's disease	0.0001	0.00102	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.79e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	9.64e-05	0.000986	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.58e-05	0.00098	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	9.57e-05	0.000979	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GCH1—Parkinson's disease	9.55e-05	0.000977	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	9.52e-05	0.000974	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	9.5e-05	0.000972	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	9.44e-05	0.000966	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	9.44e-05	0.000966	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.43e-05	0.000965	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	9.43e-05	0.000965	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	9.41e-05	0.000963	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.39e-05	0.000961	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	9.23e-05	0.000945	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	9.23e-05	0.000945	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	9.21e-05	0.000942	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	9.08e-05	0.000929	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	9.07e-05	0.000929	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	9.05e-05	0.000926	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	8.94e-05	0.000915	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	8.75e-05	0.000896	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	8.75e-05	0.000895	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	8.63e-05	0.000883	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	8.63e-05	0.000883	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	8.56e-05	0.000876	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	8.52e-05	0.000872	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—DBH—Parkinson's disease	8.51e-05	0.000871	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—FBP1—Parkinson's disease	8.51e-05	0.000871	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GBA—Parkinson's disease	8.51e-05	0.000871	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	8.44e-05	0.000864	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	8.34e-05	0.000853	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.2e-05	0.000839	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.02e-05	0.00082	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	7.94e-05	0.000812	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	7.54e-05	0.000772	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	7.46e-05	0.000763	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	7.44e-05	0.000762	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.44e-05	0.000761	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	7.38e-05	0.000755	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	7.29e-05	0.000746	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	7.28e-05	0.000745	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	7.15e-05	0.000732	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.14e-05	0.000731	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.11e-05	0.000728	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	7e-05	0.000717	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	7e-05	0.000716	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.96e-05	0.000712	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	6.87e-05	0.000703	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	6.85e-05	0.000701	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	6.72e-05	0.000687	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	6.65e-05	0.000681	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.65e-05	0.00068	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—Parkinson's disease	6.58e-05	0.000674	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ND3—Parkinson's disease	6.58e-05	0.000674	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MCCC1—Parkinson's disease	6.58e-05	0.000674	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	6.51e-05	0.000666	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	6.46e-05	0.000661	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	6.41e-05	0.000656	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	6.36e-05	0.000651	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	6.32e-05	0.000646	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	6.27e-05	0.000642	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—DDC—Parkinson's disease	6.25e-05	0.000639	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	6.24e-05	0.000638	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	6.22e-05	0.000637	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.21e-05	0.000636	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.21e-05	0.000635	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.2e-05	0.000635	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ND3—Parkinson's disease	6.2e-05	0.000635	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—OMD—Parkinson's disease	6.19e-05	0.000633	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TALDO1—Parkinson's disease	6.19e-05	0.000633	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	6.12e-05	0.000626	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	6.1e-05	0.000624	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	6.08e-05	0.000622	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	6.08e-05	0.000622	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.08e-05	0.000622	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	6.04e-05	0.000618	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	6.02e-05	0.000616	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	6.02e-05	0.000616	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.96e-05	0.00061	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	5.95e-05	0.000609	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	5.95e-05	0.000609	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	5.91e-05	0.000605	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTA4—Parkinson's disease	5.9e-05	0.000604	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	5.88e-05	0.000602	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	5.88e-05	0.000602	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.87e-05	0.0006	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—OMD—Parkinson's disease	5.83e-05	0.000597	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.83e-05	0.000597	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.64e-05	0.000577	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCH1—Parkinson's disease	5.6e-05	0.000573	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	5.56e-05	0.000569	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.53e-05	0.000566	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.52e-05	0.000565	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	5.46e-05	0.000559	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	5.46e-05	0.000559	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	5.44e-05	0.000557	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	5.34e-05	0.000547	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	5.34e-05	0.000547	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PLA2G6—Parkinson's disease	5.31e-05	0.000544	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.27e-05	0.00054	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MAOB—Parkinson's disease	5.26e-05	0.000538	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	5.23e-05	0.000535	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	5.17e-05	0.000529	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	5.12e-05	0.000523	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	5.06e-05	0.000518	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—DBH—Parkinson's disease	4.99e-05	0.00051	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—FBP1—Parkinson's disease	4.99e-05	0.00051	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GBA—Parkinson's disease	4.99e-05	0.00051	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	4.82e-05	0.000493	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	4.71e-05	0.000482	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GBA—Parkinson's disease	4.7e-05	0.000481	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.7e-05	0.000481	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—DBH—Parkinson's disease	4.7e-05	0.000481	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	4.53e-05	0.000464	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.47e-05	0.000457	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	4.44e-05	0.000454	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	4.4e-05	0.00045	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	4.37e-05	0.000448	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.36e-05	0.000446	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	4.3e-05	0.00044	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	4.28e-05	0.000438	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.21e-05	0.000431	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.18e-05	0.000428	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.12e-05	0.000422	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.11e-05	0.00042	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	4.06e-05	0.000415	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	3.97e-05	0.000406	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	3.91e-05	0.0004	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CTGF—Parkinson's disease	3.84e-05	0.000393	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	3.83e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	3.83e-05	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	3.81e-05	0.00039	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	3.76e-05	0.000384	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	3.75e-05	0.000384	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	3.74e-05	0.000383	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	3.73e-05	0.000382	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	3.68e-05	0.000377	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	3.67e-05	0.000376	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—DDC—Parkinson's disease	3.66e-05	0.000375	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.64e-05	0.000372	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	3.6e-05	0.000369	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	3.57e-05	0.000366	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	3.57e-05	0.000365	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NQO1—Parkinson's disease	3.53e-05	0.000362	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	3.49e-05	0.000357	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TH—Parkinson's disease	3.48e-05	0.000356	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.46e-05	0.000354	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—DDC—Parkinson's disease	3.45e-05	0.000353	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYCS—Parkinson's disease	3.34e-05	0.000342	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	3.33e-05	0.000341	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	3.26e-05	0.000334	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.26e-05	0.000333	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.25e-05	0.000333	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	3.23e-05	0.00033	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	3.23e-05	0.00033	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	3.16e-05	0.000323	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	3.16e-05	0.000323	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.11e-05	0.000319	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MAOB—Parkinson's disease	3.08e-05	0.000315	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—COMT—Parkinson's disease	2.96e-05	0.000303	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTP1—Parkinson's disease	2.95e-05	0.000302	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MAOA—Parkinson's disease	2.94e-05	0.000301	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.93e-05	0.0003	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—HMOX1—Parkinson's disease	2.91e-05	0.000297	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.9e-05	0.000297	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—Parkinson's disease	2.79e-05	0.000286	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—Parkinson's disease	2.71e-05	0.000277	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	2.7e-05	0.000277	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	2.65e-05	0.000271	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	2.61e-05	0.000268	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX1—Parkinson's disease	2.59e-05	0.000265	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	2.58e-05	0.000264	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	2.56e-05	0.000262	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	2.53e-05	0.000259	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—Parkinson's disease	2.39e-05	0.000245	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	2.37e-05	0.000243	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	2.32e-05	0.000238	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.29e-05	0.000234	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.26e-05	0.000231	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CTGF—Parkinson's disease	2.25e-05	0.00023	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOE—Parkinson's disease	2.23e-05	0.000228	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.21e-05	0.000226	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.12e-05	0.000217	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.1e-05	0.000215	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.09e-05	0.000214	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NQO1—Parkinson's disease	2.07e-05	0.000212	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.06e-05	0.00021	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TH—Parkinson's disease	2.04e-05	0.000209	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.97e-05	0.000202	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYCS—Parkinson's disease	1.96e-05	0.000201	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.95e-05	0.0002	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TH—Parkinson's disease	1.92e-05	0.000197	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—INS—Parkinson's disease	1.9e-05	0.000195	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.85e-05	0.000189	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	1.79e-05	0.000184	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	1.76e-05	0.00018	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—COMT—Parkinson's disease	1.74e-05	0.000178	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.73e-05	0.000177	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MAOA—Parkinson's disease	1.72e-05	0.000176	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.7e-05	0.000174	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—COMT—Parkinson's disease	1.64e-05	0.000167	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.63e-05	0.000167	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.62e-05	0.000166	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.61e-05	0.000164	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.59e-05	0.000162	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.54e-05	0.000158	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—Parkinson's disease	1.52e-05	0.000156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.5e-05	0.000153	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.43e-05	0.000147	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.4e-05	0.000144	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.34e-05	0.000137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.33e-05	0.000136	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.32e-05	0.000135	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.31e-05	0.000134	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOE—Parkinson's disease	1.31e-05	0.000134	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.3e-05	0.000133	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.23e-05	0.000126	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.23e-05	0.000126	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.2e-05	0.000123	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—INS—Parkinson's disease	1.12e-05	0.000114	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.05e-05	0.000108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	7.84e-06	8.03e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	7.67e-06	7.85e-05	CbGpPWpGaD
